echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Comfort can be initiated according to the oncology immunotherapy patient relief project

    Comfort can be initiated according to the oncology immunotherapy patient relief project

    • Last Update: 2021-01-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, the Beijing Kang League Charitable Foundation, together with Xinda Bio, launched the "Shuxin-Oncology Immunotherapy Patient Relief Project", which was launched on January 1, 2021 and is scheduled to be carried out simultaneously in project pharmacies in 190 cities across the country. The project aims to provide drug assistance to patients in urgent need of cancer immunotherapy drugs in China, and effectively reduce the financial burden on patients and families.
    According to the National Cancer Center in 2019 released national cancer statistics show that the incidence of malignant tumors to maintain an annual increase of about 3.9%, mortality rate to maintain an annual increase of 2.5%, and continuously improve the overall cancer survival rate is a clinical goal.
    to China's high morbidity and mortality rate of lung cancer as an example, the emergence of innovative treatment methods such as immunotherapy, extending the survival of patients, the future will also improve the overall survival rate of cancer patients to a certain extent. Among them, PD-1/PD-L1 inhibitors have achieved some effect on improving the survival rate of advanced cancer.
    the project relief drug Xindili single anti-injection by Xinda Bio to the Beijing Kangmen Charitable Foundation donated free of charge. Chinese mainland Patients who have not progressed in the disease after using the drug on their own, after the project doctor assessed that the conditions of the drug can continue to be used, but because of the disease can not afford the full cost of treatment patients, according to their own claims, can voluntarily launch a request for help in the "comfort can rely on" project platform, the whole of 2021 patients can accept applications for help.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.